Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers
- PMID: 16377669
- PMCID: PMC1346802
- DOI: 10.1128/AAC.50.1.68-72.2006
Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers
Abstract
Several antibiotics show significant pharmacokinetic interactions when they are given orally concomitantly with antacids. The objective of this study was to evaluate the effects of antacid (containing magnesium) on the pharmacokinetics of linezolid. A single dose of 600 mg linezolid was given orally alone and 10 min after administration of the antacid Maalox 70mVal, which contains 600 mg magnesium hydroxide and 900 mg aluminum hydroxide, to nine healthy males and nine healthy females in a crossover and randomized study. Linezolid plasma concentrations were determined by high-performance liquid chromatography, and pharmacokinetic parameters were calculated for both treatments. Coadministration with antacids did not change the pharmacokinetics of linezolid. The ratios (90% confidence intervals) of the individual values of the area under the concentration-time curve and the maximum concentration in plasma (C(max)) (linezolid plus antacid versus linezolid alone) were 1.01 (0.99 to 1.02) and 0.99 (0.96 to 1.02), respectively. Likewise, no significant difference in any of the other pharmacokinetic parameters was observed between the treatment groups (the time to C(max), lag time, volume of distribution [V/F], and clearance [CL/F]). However, a significant sex difference was observed for AUC, C(max), V/F, and CL/F; and these differences could be almost completely explained by the differences in body weight between males and females. No clinically relevant adverse effects were detected under either condition. The coadministration of antacids had no effect on the pharmacokinetics of linezolid. This demonstrates that the oral absorption of linezolid was not affected by the presence of antacids containing magnesium hydroxide and aluminum hydroxide. Antacids can be safely administered together with linezolid.
Figures
Similar articles
-
Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.Pharmacotherapy. 2007 Jul;27(7):963-9. doi: 10.1592/phco.27.7.963. Pharmacotherapy. 2007. PMID: 17594201 Clinical Trial.
-
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.Clin Pharmacokinet. 2003;42(13):1129-40. doi: 10.2165/00003088-200342130-00004. Clin Pharmacokinet. 2003. PMID: 14531724 Review.
-
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids.Br J Clin Pharmacol. 2002 Oct;54(4):372-7. doi: 10.1046/j.1365-2125.2002.01678.x. Br J Clin Pharmacol. 2002. PMID: 12392584 Free PMC article. Clinical Trial.
-
Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.Clin Pharmacokinet. 2001;40 Suppl 1:39-48. doi: 10.2165/00003088-200140001-00006. Clin Pharmacokinet. 2001. PMID: 11352441 Clinical Trial.
-
Magaldrate and almasilate--complex buffering antacids.Drug Ther Bull. 1985 May 20;23(10):39-40. Drug Ther Bull. 1985. PMID: 3888581 Review. No abstract available.
Cited by
-
The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.Eur J Clin Pharmacol. 2024 Jun;80(6):785-795. doi: 10.1007/s00228-024-03652-2. Epub 2024 Feb 29. Eur J Clin Pharmacol. 2024. PMID: 38421436 Review.
-
MDR Tuberculosis Treatment.Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188. Medicina (Kaunas). 2022. PMID: 35208510 Free PMC article. Review.
-
Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.Drugs R D. 2016 Mar;16(1):69-79. doi: 10.1007/s40268-015-0117-5. Drugs R D. 2016. PMID: 26747454 Free PMC article.
-
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.Pharmaceutics. 2011 Nov 18;3(4):865-913. doi: 10.3390/pharmaceutics3040865. Pharmaceutics. 2011. PMID: 24309312 Free PMC article.
-
Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Infect Drug Resist. 2012;5:87-102. doi: 10.2147/IDR.S25890. Epub 2012 Jun 25. Infect Drug Resist. 2012. PMID: 22787406 Free PMC article.
References
-
- Allen, A., M. Vousden, and A. Lewis. 1999. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers. Chemotherapy 45:496-503. - PubMed
-
- Allen, A., M. Vousden, A. Porter, and A. Lewis. 1999. Effect of Maalox on the bioavailability of oral gemifloxacin in healthy volunteers. Chemotherapy 45:504-511. - PubMed
-
- Bernstein, W. B., R. F. Trotta, J. T. Rector, J. A. Tjaden, and A. J. Barile. 2003. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann. Pharmacother. 37:517-520. - PubMed
-
- Boeckh, M., H. Lode, G. Hoffken, S. Daeschlein, and P. Koeppe. 1992. Pharmacokinetics of roxithromycin and influence of H2-blockers and antacids on gastrointestinal absorption. Eur. J. Clin. Microbiol. Infect. Dis. 11:465-468. - PubMed
-
- Burkhardt, O., K. Borner, N. von der Hoh, P. Koppe, M. W. Pletz, C. E. Nord, and H. Lode. 2002. Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers. J. Antimicrob. Chemother. 50:707-712. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources